Structural Modifications of siRNA Improve Its Performance In Vivo

Area of Science:

• Biomedical science
• Molecular biology
• Drug delivery systems

Background:

• Small interfering RNA (siRNA) offers therapeutic potential for incurable diseases.
• Efficient siRNA delivery to target cells and organs is a major hurdle for clinical applications.
• Liver-targeted siRNA delivery is established using N-acetylgalactosamine bioconjugation, but other organs present challenges.

Purpose of the Study:

• To review the relationship between siRNA structure (molecular weight) and its biodistribution and activity.
• To identify new strategies for improving siRNA performance in non-liver organs.
• To understand how siRNA structural properties influence cellular uptake versus organism-level distribution.

Main Methods:

• Literature review focusing on studies investigating siRNA structure-activity relationships.
• Analysis of existing data on siRNA biodistribution and therapeutic efficacy based on molecular weight.
• Synthesis of findings to correlate siRNA structural characteristics with delivery outcomes.

Main Results:

• Smaller molecular weight siRNAs generally show higher efficiency in cellular entry.
• Larger molecular weight siRNAs demonstrate advantages at the organism level for biodistribution.
• Ligand bioconjugation is crucial, but siRNA intrinsic properties significantly influence delivery.

Conclusions:

• Optimizing siRNA structure is critical for overcoming delivery challenges beyond the liver.
• Balancing cellular uptake and organism-level biodistribution requires careful consideration of siRNA molecular weight.
• Further research into structure-activity relationships can unlock new strategies for effective siRNA therapeutics.